Correlation Between Catalyst Pharmaceuticals and 00108WAQ3

Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and 00108WAQ3 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and 00108WAQ3 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Catalyst Pharmaceuticals and AEP 525 15 MAY 52, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and 00108WAQ3 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of 00108WAQ3. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and 00108WAQ3.

Diversification Opportunities for Catalyst Pharmaceuticals and 00108WAQ3

-0.14

Correlation Coefficient

Catalyst Pharmaceuticals  00108WAQ3

Good diversification

The 3 months correlation between Catalyst and 00108WAQ3 is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and AEP 525 15 MAY 52 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AEP 525 15 and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with 00108WAQ3. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AEP 525 15 has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and 00108WAQ3 go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and 00108WAQ3

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 1.24 times less return on investment than 00108WAQ3. In addition to that, Catalyst Pharmaceuticals is 1.63 times more volatile than AEP 525 15 MAY 52. It trades about 0.03 of its total potential returns per unit of risk. AEP 525 15 MAY 52 is currently generating about 0.06 per unit of volatility. If you would invest  9,372  in AEP 525 15 MAY 52 on October 26, 2024 and sell it today you would earn a total of  468.00  from holding AEP 525 15 MAY 52 or generate 4.99% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	80.0%
Values	Daily Returns

Catalyst Pharmaceuticals  vs.  AEP 525 15 MAY 52

Catalyst Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Catalyst Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

AEP 525 15

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in AEP 525 15 MAY 52 are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat abnormal basic indicators, 00108WAQ3 may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Catalyst Pharmaceuticals and 00108WAQ3

The main advantage of trading using opposite Catalyst Pharmaceuticals and 00108WAQ3 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, 00108WAQ3 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 00108WAQ3 will offset losses from the drop in 00108WAQ3's long position.

The idea behind Catalyst Pharmaceuticals and AEP 525 15 MAY 52 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.